Donnell Bowen
Impact in
-
- Colorectal Cancer Treatments and Studies
- Drug Transport and Resistance Mechanisms
-
- Cancer therapeutics and mechanisms
- Protein Structure and Dynamics
- Biochemical and Molecular Research
Papers in
-
- Cancer therapeutics and mechanisms 5
- Protein Structure and Dynamics 3
- Oncology 11
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- I. David Goldman (3 shared papers)William M. Southerland (15 shared papers)Robert B. Diasio (3 shared papers)White Jc (1 shared paper)Daniel Goldman (1 shared paper)David A. Gewirtz (1 shared paper)Goldman Id (1 shared paper)Ruth Nussinov (2 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)PLoS Computational Biology (2 papers)Journal of Molecular Graphics and Modelling (1 paper)Thorax (1 paper)Biochimica et Biophysica Acta (BBA) - Biomembranes (1 paper)
- Partner nations
- United StatesJapanIsrael
In The Last Decade
Donnell Bowen
34 papers receiving 305 citations
Peers
Comparison fields: 5 of 79
- Oncology 67
- Molecular Biology 154
- Physiology 10
- Sensory Systems 10
- Hematology 19
Countries citing papers authored by Donnell Bowen
This map shows the geographic impact of Donnell Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donnell Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donnell Bowen more than expected).
Fields of papers citing papers by Donnell Bowen
This network shows the impact of papers produced by Donnell Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donnell Bowen. The network helps show where Donnell Bowen may publish in the future.
Co-authors
The 25 scholars most cited alongside Donnell Bowen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 46 | |
| 2 | 2001 | 37 | |
| 3 | 1979 | 31 | |
| 4 | A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro. | 1978 | 30 |
| 5 | Learned food aversions and cancer anorexia. | 1981 | 30 |
| 6 | A preliminary pharmacokinetic evaluation of the antimetastatic immunomodulator swainsonine: clinical and toxic implications. | 1993 | 21 |
| 7 | The relationship among transport, intracellular binding, and inhibition of RNA synthesis by actinomycin D in Ehrlich ascites tumor cells in vitro. | 1975 | 19 |
| 8 | 2005 | 12 | |
| 9 | 1977 | 9 | |
| 10 | Interaction of swainsonine with lymphoid and highly perfused tissues: a pharmacokinetics explanation for sustained immunomodulation. | 1998 | 8 |
| 11 | Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells. | 2002 | 8 |
| 12 | Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow. | 2008 | 7 |
| 13 | Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexate. | 2006 | 6 |
| 14 | 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow. | 1999 | 6 |
| 15 | Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy. | 2006 | 4 |
| 16 | 1980 | 4 | |
| 17 | 1984 | 4 | |
| 18 | 1986 | 4 | |
| 19 | 1991 | 4 | |
| 20 | Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow. | 2007 | 3 |
About Donnell Bowen
Donnell Bowen is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Genetics, having authored 36 papers that have together received 321 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Estrogen and related hormone effects (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Protein Structure and Dynamics (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Enzyme Structure and Function (3 papers). The work is most often cited by research in Oncology (67 citations), Molecular Biology (154 citations), Physiology (10 citations), Sensory Systems (10 citations) and Hematology (19 citations). Donnell Bowen has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include I. David Goldman, William M. Southerland, Robert B. Diasio, White Jc, Daniel Goldman, David A. Gewirtz, Goldman Id, Ruth Nussinov, Zengjian Hu and Buyong Ma. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, PLoS Computational Biology, Journal of Molecular Graphics and Modelling, Thorax and Biochimica et Biophysica Acta (BBA) - Biomembranes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.